Alpha Tau to Participate in March Investor Conferences

Provided By GlobeNewswire

Last update: Feb 27, 2025

JERUSALEM, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that CFO Raphi Levy will present at the following investor conferences in March 2025.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (5/27/2025, 8:16:35 PM)

0.25

+0 (+0.04%)

DRTSW Overview

DRTSW Technical Analysis Report

DRTSW Fundamental Analysis Report

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (5/29/2025, 11:53:32 AM)

3.0468

+0.07 (+2.24%)